Antiviral Drugs: Neurotoxicity and Neurodevelopmental Effects

2,875
Total downloads
14k
Total views and downloads

Articles

EDITORIAL

Published on 26 Nov 2024

Editorial: Antiviral drugs: neurotoxicity and neurodevelopmental effects

Isabella Zanella
Daniela Zizioli
Eugenia Quiros-Roldan
Aditya N. Bade

doi 10.3389/fnmol.2024.1526357

272 views

ORIGINAL RESEARCH

Published on 06 Nov 2024

Exposure to the antiretroviral drug dolutegravir impairs structure and neurogenesis in a forebrain organoid model of human embryonic cortical development

Emma LaNoce
Daniel Y. Zhang
Alan Garcia-Epelboim
Yijing Su
Yusha Sun
Giana Alepa
Angelina R. Angelucci
Cagla Akay-Espinoza
Kelly L. Jordan-Sciutto
2 more
Kimberly M. Christian

doi 10.3389/fnmol.2024.1459877

868 views

ORIGINAL RESEARCH

Published on 17 May 2024

Dolutegravir induces FOLR1 expression during brain organoid development

Carlo Donato Caiaffa
Gabriel Tukeman
Christian Zevallos Delgado
Yogeshwari S. Ambekar
Taye T. Mekonnen
Manmohan Singh
Victoria Rodriguez
Emily Ricco
Daniel Kraushaar
4 more
Robert M. Cabrera

doi 10.3389/fnmol.2024.1394058

1,336 views
2 citations

ORIGINAL RESEARCH

Published on 05 Apr 2024

Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone

Shreya H. Dhume
Kayode Balogun
Ambalika Sarkar
Sebastian Acosta
Howard T. J. Mount
Lindsay S. Cahill
John G. Sled
Lena Serghides

doi 10.3389/fnmol.2024.1376681

1,633 views

ORIGINAL RESEARCH

Published on 29 Jan 2024

Human iPSC-derived neurons reveal NMDAR-independent dysfunction following HIV-associated insults

Alexander Starr
Emily Nickoloff-Bybel
Razan Abedalthaqafi
Naela Albloushi
Kelly L. Jordan-Sciutto

doi 10.3389/fnmol.2023.1353562

1,436 views

ORIGINAL RESEARCH

Published on 12 Dec 2023

Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model

Emma G. Foster
Brady Sillman
Yutong Liu
Micah Summerlin
Vikas Kumar
Balasrinivasa R. Sajja
Adam R. Cassidy
Benson Edagwa
Howard E. Gendelman
Aditya N. Bade

doi 10.3389/fphar.2023.1294579

2,346 views
2 citations

ORIGINAL RESEARCH

Published on 11 Dec 2023

Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures

Hubert Monnerie
Micah Romer
Lindsay M. Roth
Caela Long
John S. Millar
Kelly L. Jordan-Sciutto
Judith B. Grinspan

doi 10.3389/fnmol.2023.1323431

2,592 views

Share on

Frontiers in Molecular Neuroscience

Brain Disease Mechanisms

Participating Journals

Frontiers in Chemistry
- Medicinal and Pharmaceutical Chemistry
- 3.8 impact factor
- 8.5 citescore
Frontiers in Neurology
- NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Neuroscience
- Neurodevelopment
- Neuropharmacology
- 3.2 impact factor
- 6.2 citescore
Frontiers in Pharmacology
- Neuropharmacology
- 4.4 impact factor
- 7.8 citescore
Frontiers in Psychiatry
- NeuropharmacologyOffline
- 3.2 impact factor
- 6.2 citescore

Impact

14kTopic views
9,742Article views
2,875Article downloads

View impact

Submit your idea

Articles

Editorial: Antiviral drugs: neurotoxicity and neurodevelopmental effects

Exposure to the antiretroviral drug dolutegravir impairs structure and neurogenesis in a forebrain organoid model of human embryonic cortical development

Dolutegravir induces FOLR1 expression during brain organoid development

Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone

Human iPSC-derived neurons reveal NMDAR-independent dysfunction following HIV-associated insults

Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model

Inhibition of lipid synthesis by the HIV integrase strand transfer inhibitor elvitegravir in primary rat oligodendrocyte cultures

Frontiers in Molecular Neuroscience

Participating Journals

Impact